13F
中

NMRA NEUMORA THERAPEUTICS INC

2026Q1 · CUSIP 640979100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
113
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
51
Δ whales
+4
Inst. holding value
$137M
New positions
25
Closed positions
14
Price momentum (1Q)
-50.0%
Put / Call
3/6

Breadth history (34 quarters)

2023Q4: Δ+23 · h=61 2024Q1: Δ+27 · h=88 2024Q2: Δ+6 · h=94 2024Q3: Δ+10 · h=104 2024Q4: Δ+34 · h=138 2025Q1: Δ-21 · h=117 2025Q2: Δ-16 · h=101 2025Q3: Δ-7 · h=94 2025Q4: Δ+8 · h=102 2026Q1: Δ+11 · h=113 2023Q4: holders=61 2024Q1: holders=88 2024Q2: holders=94 2024Q3: holders=104 2024Q4: holders=138 2025Q1: holders=117 2025Q2: holders=101 2025Q3: holders=94 2025Q4: holders=102 2026Q1: holders=113 -34 -17 +0 +17 +34 54100145 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q4 Top 15% -60.1% -6.9%
2024Q1 Top 10% +22.5% +12.1%

Options Sentiment

Put holders
3
QoQ: +2
Call holders
6
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.33
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.34 2024-06-30: EPS -0.37 2024-09-30: EPS -0.45 2024-12-31: EPS -0.37 2025-03-31: EPS -0.42 2025-06-30: EPS -0.33 2025-09-30: EPS -0.35 2025-12-31: EPS -0.35 2026-03-31: EPS -0.30 -0.50 -0.25 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)